Having a clinical trial canceled is a nightmare for researchers.  If the trial stops, researchers want it to be like this.

Gastrointestinal cancers show up anywhere along the digestive tract. And while risk factors for each organ vary, a separate group of people appear to be at greater risk.

A class of drugs called CCR5 antagonists has revolutionized the care of HIV patients. These meds slow the disease from progressing to full-blown AIDS. A new preclinical study demonstrates these drugs may also be useful in cancer.

For the last fifty years, very few treatments have been available for advanced cases of melanoma, but several new drugs in the final stages of development are in competition for the title of best treatment.

Out of the top five most common cancers, lung cancer is projected to remain the deadliest, and it isn't just limited to people who smoke.

A recent presentation at the American Society of Clinical Oncology expanded on several molecular breakthroughs concerning head and neck cancers, and a team of doctors gave an overview of recent conclusions from their respective fields.

There are countless dietary supplements marketed as natural remedies for pain relief. In some instances, these supplements turn out to be neither natural nor safe, which seems to be the case for Reumofan Plus.

For many cancer researchers, the holy grail is the big jump from years of painstaking laboratory research to a final product that helps cancer patients.

It's hard to think of a disease or a condition that obesity doesn't either contribute to or aggravate. Well, researchers have found one, and one of our dailyRx contributors isn't surprised.

Doctors have to carefully watch their diabetes patients for other serious health problems like kidney disease and heart disease. Now, it seems doctors should keep an eye out for blood cancers as well.